Health - Google News: KRAS Companion Test for Erbitux Wins OK

Saturday, July 7, 2012

Health - Google News

Google News

Jul 6th 2012, 21:16

KRAS Companion Test for Erbitux Wins OK
MedPage Today
By John Gever, Senior Editor, MedPage Today A rapid molecular test for KRAS mutations has received FDA approval as an aid in identifying colorectal cancer patients who would benefit from cetuximab (Erbitux) treatment. The Therascreen KRAS test, ...
FDA Approves Qiagen KRAS Test for Use With Cancer Drug ErbituxWall Street Journal
FDA Clears Qiagen KRAS Test as CDx for ErbituxGenomeWeb
Gene test approved for selecting Erbitux patientsReuters
Sacramento Bee -FDA.gov -Bloomberg
all 22 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in:

Paparazziii